Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cryoport (CYRX) EBITDA (2016 - 2025)

Historic EBITDA for Cryoport (CYRX) over the last 17 years, with Q3 2025 value amounting to -$9.9 million.

  • Cryoport's EBITDA rose 2581.97% to -$9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$51.0 million, marking a year-over-year increase of 7147.32%. This contributed to the annual value of -$130.9 million for FY2024, which is 1364.14% down from last year.
  • Cryoport's EBITDA amounted to -$9.9 million in Q3 2025, which was up 2581.97% from -$9.6 million recorded in Q2 2025.
  • Cryoport's EBITDA's 5-year high stood at -$1.1 million during Q1 2021, with a 5-year trough of -$78.0 million in Q2 2024.
  • For the 5-year period, Cryoport's EBITDA averaged around -$17.1 million, with its median value being -$9.9 million (2025).
  • As far as peak fluctuations go, Cryoport's EBITDA plummeted by 58467.6% in 2022, and later soared by 8763.41% in 2025.
  • Cryoport's EBITDA (Quarter) stood at -$8.4 million in 2021, then plummeted by 31.97% to -$11.0 million in 2022, then plummeted by 533.18% to -$69.9 million in 2023, then soared by 68.6% to -$21.9 million in 2024, then skyrocketed by 54.73% to -$9.9 million in 2025.
  • Its last three reported values are -$9.9 million in Q3 2025, -$9.6 million for Q2 2025, and -$9.5 million during Q1 2025.